Polymorphic form of a [1, 2, 4] triazolo [4, 3-A] pyridine derivative for treating inflammatory diseases

Details for Australian Patent Application No. 2009211072 (hide)

Owner Pfizer Limited

Inventors Butcher, Kenneth John

Agent Allens Arthur Robinson

Pub. Number AU-A-2009211072

PCT Pub. Number WO2009/098612

Priority 61/025,879 04.02.08 US

Filing date 28 January 2009

Wipo publication date 13 August 2009

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

29 July 2010 PCT application entered the National Phase

  PCT publication WO2009/098612 Priority application(s): WO2009/098612

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009211078-A ground fixation device

2009211052-Immuno-detection of a cancerous state in a subject